LexaGene Holdings Inc. (CVE:LXG – Get Free Report)’s share price traded down 19.2% on Wednesday . The stock traded as low as C$0.10 and last traded at C$0.11. 2,135,375 shares were traded during trading, an increase of 1,156% from the average session volume of 170,061 shares. The stock had previously closed at C$0.13.
LexaGene Trading Down 19.2 %
The company has a debt-to-equity ratio of 138.01, a current ratio of 1.39 and a quick ratio of 1.13. The firm has a market capitalization of C$14.77 million, a PE ratio of -1.31 and a beta of 2.26. The firm’s fifty day moving average is C$0.11 and its two-hundred day moving average is C$0.11.
About LexaGene
LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.
Read More
- Five stocks we like better than LexaGene
- Investing in Travel Stocks Benefits
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- Best Stocks Under $5.00
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- Using the MarketBeat Dividend Tax Calculator
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for LexaGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LexaGene and related companies with MarketBeat.com's FREE daily email newsletter.
